Argenx had cash, cash equivalents, and other short-term investments totaling $3.4 billion as of the end of 2024, making it well-positioned to continue funding its pipeline and commercialization ...

H.I.V. treatment and services were funded through the President’s Emergency Plan for AIDS Relief, or PEPFAR, a $7.5 billion program that was frozen along with all foreign aid on Mr. Trump’s ...

Since the 1950s, first-line treatment has been glucocorticoids that have indirect and direct effects ... the main causative mechanism is a decrease in platelet count due to antiplatelet antibodies. 2 ...

This review will highlight the clinical presentation, radiographic findings, supplemental prognostic tests, differential diagnosis, surgical treatment and outcomes of INPH. Idiopathic normal ...

These hormones are effective in the treatment of idiopathic thrombocytopenic purpura presumably on the basis of their immunosuppressive effect and by improvement in capillary integrity.

and evolving Thrombotic Thrombocytopenic Purpura treatment options. The report discusses key statistics, including current and projected market sizes, while delving into Thrombotic Thrombocytopenic ...

This includes a detailed review of ongoing and upcoming studies that are set to shape the future of Thrombotic Thrombocytopenic Purpura treatment. With its rich data and forward-looking insights ...

Introduction: Idiopathic purpura fulminans (IPF) is a rare and severe coagulation disorder, associated with transient anti-protein S (anti-PS) antibodies in the context of post-viral infection such as ...

Primary immune thrombocytopenia (ITP), formerly known as idiopathic thrombocytopenic purpura, is an autoimmune disorder characterized by peripheral ... severity, and responsiveness to treatment (Proal ...